GAD1 is a biomarker for benign and malignant prostatic tissue

By Jaraj Sara Jonmarker   Augsten Martin   Hääggarth Lars   Wester Kenneth   Pontéén Fredrik   ÖÖstman Arne   Egevad Lars  

Scandinavian Journal of Urology and Nephrology, Vol. 45, Iss. 1, 2011-02 ,pp. : 39-45

Informa Healthcare

Access to resources Recommend Favorite

Correlation of histological inflammation in needle biopsy specimens with serum prostate- specific antigen levels in men with negative biopsy for prostate cancer

By Okada K.   Kojima M.   Naya Y.   Kamoi K.   Yokoyama K.   Takamatsu T.   Miki T.  

Urology, Vol. 55, Iss. 6, 2000-06 ,pp. : 892-898

Elsevier

Access to resources Recommend Favorite

Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy? - results of a randomized, double-blind, placebo-controlled clinical trial

By Yang X.J.   Lecksell K.   Short K.   Gottesman J.   Peterson L.   Bannow J.   Schellhammer P.F.   Fitch W.P.   Hodge G.B.   Parra R.   Rouse S.   Waldstreicher J.   Epstein J.I.  

Urology, Vol. 53, Iss. 4, 1999-04 ,pp. : 696-700

Elsevier

Access to resources Recommend Favorite

The Rate of Tumour Growth Does Not Distinguish Between Malignant and Benign Thyroid Nodules

By Asanuma Kazuhiko   Kobayashi Shinya   Shingu Kiyosi   Hama Yoshihisa   Yokoyama Shiro   Fujimori Minoru   Amano Jun  

European Journal of Surgery, Vol. 167, Iss. 2, 2001-02 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite

Determination of alpha 1 -antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA

By Jung K.   Brux B.   Lein M.   Knabich A.   Sinha P.   Rudolph B.   Schnorr D.   Loening S.A.  

Urology, Vol. 53, Iss. 6, 1999-06 ,pp. : 1160-1167

Elsevier

Access to resources Recommend Favorite